반응식
[NH2:1][C:2]1[CH:3]=[CH:4][C:5]([F:17])=[C:6]([C@:8]2([CH3:16])[C@@H:13]([F:14])[CH2:12][O:11][C:10]([NH2:15])=[N:9]2)[CH:7]=1.[S:18]1[C:22]([C:23](O)=[O:24])=[CH:21][N:20]=[CH:19]1>>[NH2:15][C:10]1[O:11][CH2:12][C@H:13]([F:14])[C@:8]([C:6]2[CH:7]=[C:2]([NH:1][C:23]([C:22]3[S:18][CH:19]=[N:20][CH:21]=3)=[O:24])[CH:3]=[CH:4][C:5]=2[F:17])([CH3:16])[N:9]=1참가 물질
3
실험 절차
The condensation of (4R,5R)-4-(5-amino-2-fluoro-phenyl)-5-fluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-2-ylamine (intermediate A8.2) and thiazole-5-carboxylic acid (CAS 14527-41-4) following procedure I yielded the title compound as a white solid. MS (ISP): m/z=353.2 [M+H]+.
출처 및 근거
- ORD 기록
- ord-7f335f6ea9cc4383973c54d53301129f
- 출처 데이터셋
- uspto-grants-2014_06
- 특허 번호
- US08754075B2
연결된 노트
불러오는 중…